Pomalidomide alone or in combination with dexamethasone in Japanese patients with refractory or relapsed and refractory multiple myeloma

This phase 1, open‐label, dose‐escalation study investigated the tolerated dose (recommended dose), safety, efficacy, and pharmacokinetics of pomalidomide alone or pomalidomide plus low‐dose dexamethasone in Japanese patients with refractory or relapsed and refractory multiple myeloma. Twelve patien...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Cancer Sci
Hoofdauteurs: Matsue, Kosei, Iwasaki, Hiromi, Chou, Takaaki, Tobinai, Kensei, Sunami, Kazutaka, Ogawa, Yoshiaki, Kurihara, Mari, Midorikawa, Shuichi, Zaki, Mohamed, Doerr, Thomas, Iida, Shinsuke
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: John Wiley and Sons Inc. 2015
Onderwerpen:
Original Articles
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4714698/
https://ncbi.nlm.nih.gov/pubmed/26292221
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.12772
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items